Year: 1999
Type: article
Abstract: Nearly three decades have passed since Sir John Vane correctly hypothesized that nonsteroidal anti-inflammatory drugs (NSAIDs), in wide use mainly for the treatment of pain and inflammation in osteoarthritis and rheumatoid arthritis, act by inhibiting the catalytic activity of the enzyme cyclooxygenase (COX). The chief pitfalls of using these medications are that, while ameliorating pain and inflammation, they also disrupt the homeostatic activities of the prostaglandins formed by COX.
Source: The American Journal of Medicine
Author: Peter E Lipsky
Institution: The University of Texas Southwestern Medical Center
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,770
OpenAlex ID: W2625231424
